Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/dinto_DB00461
http://purl.obolibrary.org/obo/dinto_DB00461
|
|---|---|
| Preferred Name | nabumetone |
| Synonyms |
4-(6-methoxynaphthalen-2-yl)butan-2-one
C15H16O2
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | nabumetone
|
|---|---|
| label | nabumetone
|
| DBSynonym |
nabumetona
nabumetonum [inn-latin]
|
| ATCCode | M01AX01
|
| Definition | Nabumetone is a nonsteroidal anti-inflammatory drug (NSAID) of the arylalkanoic acid family (which includes diclofenac). Marketed under the brand name Relafen, it has been shown to have a slightly lower risk of gastrointestinal side effects than most other non-selective NSAIDs.
|
| has effect |
See more
See less
|
| has pharmacological target | |
| inhibits | |
| type | |
| InChIKey | InChIKey=BLXXJMDCKKHMKV-UHFFFAOYSA-N
|
| is metabolised by | |
| AHFScode | 28:08.04.92
|
| Synonym |
4-(6-methoxynaphthalen-2-yl)butan-2-one
C15H16O2
|
| xref |
Drugs Product Database (DPD):2238639
PubChem Compound:4409
Drugs.com:http://www.drugs.com/cdi/nabumetone.html
PharmGKB:PA450572
PubChem Substance:46507729
National Drug Code Directory:49884-649-01
RxList:http://www.rxlist.com/cgi/generic/nabume.htm
BindingDB:50240662
PDRhealth:http://www.pdrhealth.com/drug_info/rxdrugprofiles/drugs/rel1370.shtml
ChemSpider:4256
Wikipedia:http://en.wikipedia.org/wiki/Nabumetone
See more
See less
|
| CASRN | 42924-53-8
|
| prefixIRI | obo2:dinto_DB00461
|
| SMILES | COC1=CC2=C(C=C1)C=C(CCC(C)=O)C=C2
|
| may interact with |
See more
See less
|
| InChI | InChI=1S/C15H16O2/c1-11(16)3-4-12-5-6-14-10-15(17-2)8-7-13(14)9-12/h5-10H,3-4H2,1-2H3
|
| DBBrand |
arthaxan
unimetone
balmox
relifex
dolsinal
mebutan
relifen
nabuser
prodac
flambate
relif
consolan
relafen
listran
See more
See less
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |